When 1.6 million adults in England, Wales, and Scotland used GLP-1 medications for weight loss in the past year, one thing became clear: the demand is already here, and it is large enough to reshape how private weight loss care is delivered. As more individuals choose to use weight loss medication, healthcare professionals are placing greater emphasis on long-term guidance, nutritional support, and ongoing clinical monitoring. Brown's Pharma Limited, which operates the UK pharmacy brand Lyv, says that gap is where many online services fall short. The company launched Lyv to support adults using private weight loss medication with a model built around ongoing contact rather than a one-time prescription process. The first mention of the brand is on lyvpharmacy.com, where the service is presented as a UK pharmacy offering prescription weight loss support alongside other treatments.
The Support Gap Behind The Boom
The scale of GLP-1 use in Britain has changed quickly. A UCL study published in January estimated that 1.6 million adults used drugs such as Wegovy and Mounjaro for weight loss over the previous year, while 910,000 said they used them exclusively for that purpose. That level of use has pushed weight loss care further into the private sector, where access is often faster but follow-up can be thinner.
That is where the concern begins. GLP 1 drugs work by reducing appetite, which can mean patients eat much less than before. A 2026 review of the evidence found that nutritional deficiencies are a growing issue for some users, with vitamin D, iron, calcium, and B vitamins among the more common shortfalls reported in the literature. The same review pointed to the need for routine nutritional assessment during treatment.
"Many people are excited to start treatment, but the real journey begins afterwards," says a Lyv spokesperson. "Questions about nutrition, side effects, dosage adjustments and long-term goals often arise once treatment is underway. Having access to guidance at that stage can make a significant difference."
Why Ongoing Care Matters
Weight loss medications can help reduce appetite and support weight reduction, but they do not automatically teach people how to maintain healthy nutrition, protect muscle mass, build sustainable habits, or manage changes in their lifestyle.
For many people, eating significantly less than before can make it more difficult to consume adequate protein, vitamins, and minerals. Others may need reassurance about expected side effects or support when progressing through different treatment strengths.
This is why LYV has built its service around continuity of care rather than a one-off transaction. Patients have access to ongoing support, treatment guidance, and a clinical team that remains available throughout their journey.
"Weight loss medication is a tool, not a complete solution," the spokesperson explains. "People often need support understanding how to get the best results while maintaining their overall health and wellbeing."
A Market With More Demand Than Structure
The weight loss medication market in the UK is still being shaped by a mismatch between demand and clinical capacity. Government guidance published in 2025 says GLP-1 medicines should be used for specific medical indications and not for cosmetic weight loss. At the same time, private demand remains strong because many patients do not meet NHS thresholds or cannot access treatment quickly through public routes.
That pressure has created a large private market, but not every provider has built the same support around it. Some services focus mainly on speed of approval and delivery. Lyv is entering with a different pitch, one centred on continuity of care, direct communication, and a pharmacy team that stays involved during treatment.
"Weight loss medication is only one part of the process," the spokesperson said. "What happens after the prescription is just as important, because that is where patients need reassurance, adjustments and practical advice."
What Lyv Is Offering
LYV provides access to prescription weight loss treatments for eligible adults across the UK, supported by a structured and clinically guided patient journey.
Patients receive clinician review, ongoing treatment support, access to healthcare professionals when questions arise, and guidance designed to help them navigate challenges such as appetite changes, nutritional intake, side effects, and treatment progression.
The platform was built around a simple belief: people deserve support before, during, and after treatment.
"Our goal is not simply to help someone start treatment," says the LYV team. "It is to help them feel informed, supported and confident throughout their entire journey."
As the number of adults using GLP-1 medications continues to rise, the conversation is increasingly shifting from access alone to long-term outcomes. LYV believes that medication works best when combined with education, support, and continuity of care — helping patients build healthier habits that last beyond the prescription itself.
About LYV
LYV is a UK online healthcare platform that provides access to clinician-reviewed treatments across weight management, men's health, hair health, and wellbeing. Through a combination of digital consultations, ongoing support, and discreet delivery, LYV aims to make healthcare more accessible, convenient, and patient-focused for adults across the UK.
